Bayesian Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-25,700	Closed	-$493K	–	991
2024 Q4	$493K	Buy	25,700 +12,800	+99%	+$245K	0.06%	373
2024 Q3	$293K	Sell	12,900 -15,782	-55%	-$359K	0.03%	481
2024 Q2	$373K	Buy	+28,682	New	+$373K	0.04%	447